WASHINGTON, Sept. 30, 2021 /PRNewswire/ -- The Antimicrobials
Working Group (AWG), a coalition of companies with the mission to
combat drug resistant infections and spur life-saving innovations,
today announced that 10 of its member companies will present data
from their clinical and research programs at IDWeek 2021 taking
place virtually from September 29-October 3,
2021. AWG members are presenting a total of 23 poster
presentations and 3 oral abstract presentations.
IDWeek is the joint annual meeting of the Infectious Diseases
Society of America (IDSA), Society for Healthcare Epidemiology of
America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric
Infectious Diseases Society (PIDS), and the Society of Infectious
Diseases Pharmacists (SIDP).
"AWG is thrilled to be so well represented at this year's IDWeek
conference," said Ted Schroeder,
Chief Executive Officer of Nabriva Therapeutics and Chairman of
AWG. "The COVID-19 pandemic has provided a stark reminder of the
need for preparedness against emerging infectious disease threats,
not the least of which includes supporting innovation of safe and
effective antimicrobials for dangerous, and hard to treat,
drug-resistant pathogens. Presentations from AWG member companies
will highlight the latest developments in the fight against
superbugs and drug resistant infections."
For more information on AWG member company posters and
participation please visit:
https://antimicrobialsworkinggroup.org/idweek-2021/
About The Antimicrobials Working Group
AWG was
founded in 2012 with the vision of utilizing collective power to
improve the regulatory, investment, and commercial environment for
emerging infectious disease companies. Today, AWG is comprised of
fourteen antimicrobials companies: Acurx Pharmaceuticals, Inc.
(NASDAQ: ACXP), Cidara Therapeutics Inc. (NASDAQ: CDTX), CorMedix,
Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum
Therapeutics Ltd. (NASDAQ: ITRM), Melinta Therapeutics Inc.
(NASDAQ: MLNT), Nabriva Therapeutics US Inc. (NASDAQ: NBRV),
Paratek Pharmaceuticals Inc. (NASDAQ: PRTK), Qpex Biopharma, Inc.,
SCYNEXIS Inc. (NASDAQ: SCYX), Summit Therapeutics plc (NASDAQ:
SMMT) (AIM: SUMM), UTILITY therapeutics Ltd., and Venatorx
Pharmaceuticals, Inc.
For more information, visit:
www.antimicrobialsworkinggroup.org
About The Conafay Group
The Conafay Group, led by
Stephen R. Conafay, Principal, is a
life-sciences government relations firm based in Washington D.C. that serves as Washington counsel and coalition manager for
AWG.
For more information, visit: www.conafaygroup.com
Media Contact: conafay@conafaygroup.com
View original
content:https://www.prnewswire.com/news-releases/antimicrobials-working-group-highlights-member-company-participation-at-idweek-2021-301388427.html
SOURCE Antimicrobials Working Group (AWG)